Michael A. Caligiuri
Fondateur chez Cytoimmune Therapeutics, Inc.
Profil
Michael A.
Caligiuri is the founder of Cytoimmune Therapeutics, Inc. founded in 2019, where he holds the title of Chief Medical Officer.
He currently holds positions as Director of the Comprehensive Cancer Center at The Ohio University, Director at The Ohio State University Wexner Medical Center, Director at Pelotonia, and Co-President at City of Hope National Medical Center.
In the past, he held the position of Chief Executive Officer at James Cancer Hospital and Chief Executive Officer & Director at Ohio State University Comprehensive Cancer Center.
He also served as an Independent Member-Supervisory Board at Innate Pharma SA and President-Elect at American Association for Cancer Research.
Postes actifs de Michael A. Caligiuri
| Sociétés | Poste | Début |
|---|---|---|
The Ohio University
 The Ohio University Other Consumer ServicesConsumer Services Central Hockey League operates a professional minor league hockey teams playing in small to medium-sized markets primarily in central and southwestern US states. The league, which was started in 1992, is managed and operated by WPHL, a subsidiary of Global Entertainment Corporation. | Corporate Officer/Principal | - |
The Ohio State University Wexner Medical Center
 The Ohio State University Wexner Medical Center Medical/Nursing ServicesHealth Services The Ohio State University Wexner Medical Center provides healthcare services. It offers health and wellness services, health care services such as allergy immunology care, arthritis rheumatology, brain and spine, orthopedics, palliative care, transplant center and wound healing. The company was founded in 1834 and is headquartered in Columbus, OH. | Directeur/Membre du Conseil | - |
Pelotonia
 Pelotonia Miscellaneous Commercial ServicesCommercial Services Pelotonia engages in fund life-saving cancer research. It focuses on end to cancer. The company was founded in 2008 and is headquartered in Columbus, OH. | Directeur/Membre du Conseil | - |
Cytoimmune Therapeutics, Inc.
 Cytoimmune Therapeutics, Inc. BiotechnologyHealth Technology Cytoimmune Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2017 and based in Toa, Japan. The American company is focused on developing a pipeline of NK cell therapies for various types of cancer, including lung cancer, acute myeloid leukemia, solid tumors, and multiple myeloma. The private company's lead product, Cyto-102, is a track-NK cell therapy that aims to enter clinical trials in combination with atezolizumab for non-small cell lung cancer in 2022. Cytoimmune Therapeutics also offers cell therapy development and clinical manufacturing services to biotechnology companies and academia. The company's state-of-the-art clinical cell manufacturing facility is custom-built to support the development and commercialization of cutting-edge T cell or NK cell therapies. The company was founded in 2017 by Michael A. Caligiuri, William Michael Rosellini, and Jianhua Yu, Ph.D. José Eduardo Vidal has been the CEO of the company since 2021. | Fondateur | 01/06/2019 |
City of Hope National Medical Center
 City of Hope National Medical Center BiotechnologyHealth Technology City of Hope National Medical Center is an independent biomedical, treatment, and education center that focuses on basic and clinical research in cancer, diabetes, and other chronic, life-threatening diseases. The non-profit company is based in Duarte, CA. City of Hope offers virtual tours of its world-renowned facilities, where people can learn about the company's efforts to make a difference in the lives of those with serious illnesses such as cancer and diabetes. The company was founded in 1913. Robert W. Stone has been the CEO of the company since 1996. | President | - |
Anciens postes connus de Michael A. Caligiuri
| Sociétés | Poste | Fin |
|---|---|---|
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | President | 18/04/2018 |
James Cancer Hospital
 James Cancer Hospital Hospital/Nursing ManagementHealth Services James Cancer Hospital operates cancer hospitals. The private company is based in Dublin, OH. | Directeur Général | 15/11/2017 |
Ohio State University Comprehensive Cancer Center
 Ohio State University Comprehensive Cancer Center Miscellaneous Commercial ServicesCommercial Services Ohio State University Comprehensive Cancer Center provides cancer care services. It Specializes in cancer care and treatment, cancer types, benign blood diseases, cancer clinics and centers, clinical services, nursing at OSUCCC – james, genetic counseling, find a clinical trial, find a doctor, online bill pay, OSU MyChart and referring physicians. The company was founded by Arthur G. James in 1973 and is headquartered in Columbus, OH. | Directeur Général | - |
| INNATE PHARMA | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INNATE PHARMA | Health Technology |
| Entreprise privées | 7 |
|---|---|
James Cancer Hospital
James Cancer Hospital Hospital/Nursing ManagementHealth Services James Cancer Hospital operates cancer hospitals. The private company is based in Dublin, OH. | Health Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
The Ohio State University Wexner Medical Center
The Ohio State University Wexner Medical Center Medical/Nursing ServicesHealth Services The Ohio State University Wexner Medical Center provides healthcare services. It offers health and wellness services, health care services such as allergy immunology care, arthritis rheumatology, brain and spine, orthopedics, palliative care, transplant center and wound healing. The company was founded in 1834 and is headquartered in Columbus, OH. | Health Services |
Pelotonia
Pelotonia Miscellaneous Commercial ServicesCommercial Services Pelotonia engages in fund life-saving cancer research. It focuses on end to cancer. The company was founded in 2008 and is headquartered in Columbus, OH. | Commercial Services |
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center Miscellaneous Commercial ServicesCommercial Services Ohio State University Comprehensive Cancer Center provides cancer care services. It Specializes in cancer care and treatment, cancer types, benign blood diseases, cancer clinics and centers, clinical services, nursing at OSUCCC – james, genetic counseling, find a clinical trial, find a doctor, online bill pay, OSU MyChart and referring physicians. The company was founded by Arthur G. James in 1973 and is headquartered in Columbus, OH. | Commercial Services |
Cytoimmune Therapeutics, Inc.
Cytoimmune Therapeutics, Inc. BiotechnologyHealth Technology Cytoimmune Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2017 and based in Toa, Japan. The American company is focused on developing a pipeline of NK cell therapies for various types of cancer, including lung cancer, acute myeloid leukemia, solid tumors, and multiple myeloma. The private company's lead product, Cyto-102, is a track-NK cell therapy that aims to enter clinical trials in combination with atezolizumab for non-small cell lung cancer in 2022. Cytoimmune Therapeutics also offers cell therapy development and clinical manufacturing services to biotechnology companies and academia. The company's state-of-the-art clinical cell manufacturing facility is custom-built to support the development and commercialization of cutting-edge T cell or NK cell therapies. The company was founded in 2017 by Michael A. Caligiuri, William Michael Rosellini, and Jianhua Yu, Ph.D. José Eduardo Vidal has been the CEO of the company since 2021. | Health Technology |
City of Hope National Medical Center
City of Hope National Medical Center BiotechnologyHealth Technology City of Hope National Medical Center is an independent biomedical, treatment, and education center that focuses on basic and clinical research in cancer, diabetes, and other chronic, life-threatening diseases. The non-profit company is based in Duarte, CA. City of Hope offers virtual tours of its world-renowned facilities, where people can learn about the company's efforts to make a difference in the lives of those with serious illnesses such as cancer and diabetes. The company was founded in 1913. Robert W. Stone has been the CEO of the company since 1996. | Health Technology |
